View Filing Data

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2016	Aug. 01, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2
Trading Symbol	MPW
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		243,138,873
MPT Operating Partnership, L.P. [Member]
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2
Entity Registrant Name	MPT OPERATING PARTNERSHIP, L.P.
Entity Central Index Key	0001524607
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Real estate assets
Land, buildings and improvements, intangible lease assets, and other	$ 3,482,199	$ 3,297,705
Real estate held for sale	63,074
Mortgage loans	549,337	757,581
Net investment in direct financing leases	528,747	626,996
Gross investment in real estate assets	4,623,357	4,682,282
Accumulated depreciation and amortization	(278,590)	(257,928)
Net investment in real estate assets	4,344,767	4,424,354
Cash and cash equivalents	181,561	195,541
Interest and rent receivables	47,699	46,939
Straight-line rent receivables	95,988	82,155
Other loans	259,329	664,822
Other assets	188,589	195,540
Total Assets	5,117,933	5,609,351
Liabilities
Debt, net	2,758,635	3,322,541
Accounts payable and accrued expenses	148,218	137,356
Deferred revenue	20,997	29,358
Lease deposits and other obligations to tenants	22,845	12,831
Total Liabilities	2,950,695	3,502,086
Equity / Capital
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 240,341 shares at June 30, 2016 and 236,744 shares at December 31, 2015	240	237
Limited Partners:
Additional paid in capital	2,642,281	2,593,827
Distributions in excess of net income	(414,657)	(418,650)
Accumulated other comprehensive loss	(65,340)	(72,884)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. Stockholders' Equity	2,162,262	2,102,268
Non-controlling interests	4,976	4,997
Total Equity / Capital	2,167,238	2,107,265
Total Liabilities and Equity / Capital	5,117,933	5,609,351
MPT Operating Partnership, L.P. [Member]
Real estate assets
Land, buildings and improvements, intangible lease assets, and other	3,482,199	3,297,705
Real estate held for sale	63,074
Mortgage loans	549,337	757,581
Net investment in direct financing leases	528,747	626,996
Gross investment in real estate assets	4,623,357	4,682,282
Accumulated depreciation and amortization	(278,590)	(257,928)
Net investment in real estate assets	4,344,767	4,424,354
Cash and cash equivalents	181,561	195,541
Interest and rent receivables	47,699	46,939
Straight-line rent receivables	95,988	82,155
Other loans	259,329	664,822
Other assets	188,589	195,540
Total Assets	5,117,933	5,609,351
Liabilities
Debt, net	2,758,635	3,322,541
Accounts payable and accrued expenses	92,623	84,628
Deferred revenue	20,997	29,358
Lease deposits and other obligations to tenants	22,845	12,831
Payable due to Medical Properties Trust, Inc.	55,205	52,338
Total Liabilities	2,950,305	3,501,696
Limited Partners:
Accumulated other comprehensive loss	(65,340)	(72,884)
Total Medical Properties Trust, Inc. Stockholders' Equity	2,162,652	2,102,658
Non-controlling interests	4,976	4,997
Total Equity / Capital	2,167,628	2,107,655
Total Liabilities and Equity / Capital	5,117,933	5,609,351
MPT Operating Partnership, L.P. [Member] \| General Partner [Member]
Equity / Capital
General Partner - issued and outstanding - 2,400 units at June 30, 2016 and 2,363 units at December 31, 2015	22,299	21,773
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Limited Partners:
Limited Partners Capital	$ 2,205,693	$ 2,153,769

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2016	Dec. 31, 2015
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	240,341,000	236,744,000
Common stock, shares outstanding	240,341,000	236,744,000
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Limited Partners, units issued	237,941,000	234,381,000
Limited Partners, units outstanding	237,941,000	234,381,000
General Partner [Member] \| MPT Operating Partnership, L.P. [Member]
General partner, units issued	2,400,000	2,363,000
General partner, units outstanding	2,400,000	2,363,000
LTIP Units [Member] \| MPT Operating Partnership, L.P. [Member]
LTIP Units, shares issued	292,000	292,000
LTIP Units, shares outstanding	292,000	292,000

Condensed Consolidated Statements of Net Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenues
Rent billed	$ 77,960	$ 53,893	$ 152,021	$ 106,994
Straight-line rent	8,551	5,252	16,768	9,980
Income from direct financing leases	13,552	12,808	32,503	25,363
Interest and fee income	26,237	27,848	60,007	53,425
Total revenues	126,300	99,801	261,299	195,762
Expenses
Real estate depreciation and amortization	22,832	14,956	43,974	29,712
Impairment charges	7,375		7,375
Property-related	784	530	1,685	881
General and administrative	12,045	10,642	23,516	21,547
Acquisition expenses	4,767	25,809	3,702	32,048
Total operating expenses	47,803	51,937	80,252	84,188
Operating income	78,497	47,864	181,047	111,574
Other income (expense)
Interest expense	(41,501)	(26,890)	(80,874)	(53,556)
Gain on sale of real estate and other asset dispositions, net	16,638		16,678
Earnings (loss) from equity and other interests	1,200	1,853	(3,801)	1,956
Other income (expense)	(546)	225	(217)	(571)
Income tax expense	(364)	(563)	(683)	(938)
Net other expense	(24,573)	(25,375)	(68,897)	(53,109)
Income from continuing operations	53,924	22,489	112,150	58,465
Loss from discontinued operations			(1)
Net income	53,924	22,489	112,149	58,465
Net income attributable to non-controlling interests	(200)	(82)	(498)	(161)
Net income attributable to MPT common stockholders	$ 53,724	$ 22,407	$ 111,651	$ 58,304
Earnings per common share - basic
Income from continuing operations attributable to MPT common stockholders	$ 0.23	$ 0.11	$ 0.47	$ 0.28
Loss from discontinued operations attributable to MPT common stockholders	0	0	0	0
Net income attributable to MPT common stockholders	$ 0.23	$ 0.11	$ 0.47	$ 0.28
Weighted average shares outstanding - basic	238,082	208,071	237,796	205,515
Earnings per common share - diluted
Income from continuing operations attributable to MPT common stockholders	$ 0.22	$ 0.11	$ 0.47	$ 0.28
Loss from discontinued operations attributable to MPT common stockholders	0	0	0	0
Net income attributable to MPT common stockholders	$ 0.22	$ 0.11	$ 0.47	$ 0.28
Weighted average shares outstanding - diluted	239,008	208,640	238,413	206,127
Dividends declared per common share	$ 0.23	$ 0.22	$ 0.45	$ 0.44
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 77,960	$ 53,893	$ 152,021	$ 106,994
Straight-line rent	8,551	5,252	16,768	9,980
Income from direct financing leases	13,552	12,808	32,503	25,363
Interest and fee income	26,237	27,848	60,007	53,425
Total revenues	126,300	99,801	261,299	195,762
Expenses
Real estate depreciation and amortization	22,832	14,956	43,974	29,712
Impairment charges	7,375		7,375
Property-related	784	530	1,685	881
General and administrative	12,045	10,642	23,516	21,547
Acquisition expenses	4,767	25,809	3,702	32,048
Total operating expenses	47,803	51,937	80,252	84,188
Operating income	78,497	47,864	181,047	111,574
Other income (expense)
Interest expense	(41,501)	(26,890)	(80,874)	(53,556)
Gain on sale of real estate and other asset dispositions, net	16,638		16,678
Earnings (loss) from equity and other interests	1,200	1,853	(3,801)	1,956
Other income (expense)	(546)	225	(217)	(571)
Income tax expense	(364)	(563)	(683)	(938)
Net other expense	(24,573)	(25,375)	(68,897)	(53,109)
Income from continuing operations	53,924	22,489	112,150	58,465
Loss from discontinued operations			(1)
Net income	53,924	22,489	112,149	58,465
Net income attributable to non-controlling interests	(200)	(82)	(498)	(161)
Net income attributable to MPT common stockholders	$ 53,724	$ 22,407	$ 111,651	$ 58,304
Earnings per common share - basic
Income from continuing operations attributable to MPT common stockholders	$ 0.23	$ 0.11	$ 0.47	$ 0.28
Loss from discontinued operations attributable to MPT common stockholders	0	0	0	0
Net income attributable to MPT common stockholders	$ 0.23	$ 0.11	$ 0.47	$ 0.28
Weighted average shares outstanding - basic	238,082	208,071	237,796	205,515
Earnings per common share - diluted
Income from continuing operations attributable to MPT common stockholders	$ 0.22	$ 0.11	$ 0.47	$ 0.28
Loss from discontinued operations attributable to MPT common stockholders	0	0	0	0
Net income attributable to MPT common stockholders	$ 0.22	$ 0.11	$ 0.47	$ 0.28
Weighted average shares outstanding - diluted	239,008	208,640	238,413	206,127
Dividends declared per common share	$ 0.23	$ 0.22	$ 0.45	$ 0.44

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net income	$ 53,924	$ 22,489	$ 112,149	$ 58,465
Other comprehensive income:
Unrealized gain on interest rate swap	825	730	1,640	1,315
Foreign currency translation gain (loss)	(14,683)	20,307	5,904	(39,286)
Total comprehensive income	40,066	43,526	119,693	20,494
Comprehensive income attributable to non-controlling interests	(200)	(82)	(498)	(161)
Comprehensive income attributable to MPT common stockholders	39,866	43,444	119,195	20,333
MPT Operating Partnership, L.P. [Member]
Net income	53,924	22,489	112,149	58,465
Other comprehensive income:
Unrealized gain on interest rate swap	825	730	1,640	1,315
Foreign currency translation gain (loss)	(14,683)	20,307	5,904	(39,286)
Total comprehensive income	40,066	43,526	119,693	20,494
Comprehensive income attributable to non-controlling interests	(200)	(82)	(498)	(161)
Comprehensive income attributable to MPT common stockholders	$ 39,866	$ 43,444	$ 119,195	$ 20,333

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating activities
Net income	$ 112,149	$ 58,465
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	45,170	30,564
Straight-line rent revenue	(17,268)	(9,980)
Straight-line rent and other write-off	3,063
Impairment charges	7,375
Direct financing lease interest accretion	(4,766)	(3,279)
Share / (Unit)-based compensation expense	4,152	5,645
Gain from sale of real estate and other asset dispositions, net	(16,678)
Amortization and write-off of deferred financing costs and debt discount	3,897	2,770
Other adjustments	(6,605)	(2,383)
Changes in:
Interest and rent receivable	(2,743)	(15,685)
Accounts payable and accrued expenses	9,544	21,327
Net cash provided by operating activities	137,290	87,444
Investing activities
Cash paid for acquisitions and other related investments	(109,991)	(562,633)
Net proceeds from sale of real estate	89,165
Principal received on loans receivable	705,501	354,952
Investment in loans receivable	(96,504)	(347,768)
Construction in progress and other	(108,065)	(86,053)
Investment in unsecured senior note	(50,000)
Proceeds from sale of unsecured senior notes	50,000
Net cash provided by (used for) investing activities	480,106	(641,502)
Financing activities
Revolving credit facilities, net	(1,075,000)	80,586
Proceeds from debt	500,000
Payments of term debt	(147)	(140)
Distributions paid	(104,788)	(84,487)
Proceeds from sale of common shares / units, net of offering costs	44,306	479,902
Lease deposits and other obligations to tenants	9,593	(14,453)
Debt issuance costs paid and other financing activities	(8,465)	(662)
Net cash (used for) provided by financing activities	(634,501)	460,746
Increase (decrease) in cash and cash equivalents for period	(17,105)	(93,312)
Effect of exchange rate changes	3,125	(5,325)
Cash and cash equivalents at beginning of period	195,541	144,541
Cash and cash equivalents at end of period	181,561	45,904
Interest paid	57,118	52,130
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	55,272	46,026
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	112,149	58,465
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	45,170	30,564
Straight-line rent revenue	(17,268)	(9,980)
Straight-line rent and other write-off	3,063
Impairment charges	7,375
Direct financing lease interest accretion	(4,766)	(3,279)
Share / (Unit)-based compensation expense	4,152	5,645
Gain from sale of real estate and other asset dispositions, net	(16,678)
Amortization and write-off of deferred financing costs and debt discount	3,897	2,770
Other adjustments	(6,605)	(2,383)
Changes in:
Interest and rent receivable	(2,743)	(15,685)
Accounts payable and accrued expenses	9,544	21,327
Net cash provided by operating activities	137,290	87,444
Investing activities
Cash paid for acquisitions and other related investments	(109,991)	(562,633)
Net proceeds from sale of real estate	89,165
Principal received on loans receivable	705,501	354,952
Investment in loans receivable	(96,504)	(347,768)
Construction in progress and other	(108,065)	(86,053)
Investment in unsecured senior note	(50,000)
Proceeds from sale of unsecured senior notes	50,000
Net cash provided by (used for) investing activities	480,106	(641,502)
Financing activities
Revolving credit facilities, net	(1,075,000)	80,586
Proceeds from debt	500,000
Payments of term debt	(147)	(140)
Distributions paid	(104,788)	(84,487)
Proceeds from sale of common shares / units, net of offering costs	44,306	479,902
Lease deposits and other obligations to tenants	9,593	(14,453)
Debt issuance costs paid and other financing activities	(8,465)	(662)
Net cash (used for) provided by financing activities	(634,501)	460,746
Increase (decrease) in cash and cash equivalents for period	(17,105)	(93,312)
Effect of exchange rate changes	3,125	(5,325)
Cash and cash equivalents at beginning of period	195,541	144,541
Cash and cash equivalents at end of period	181,561	45,904
Interest paid	57,118	52,130
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$ 55,272	$ 46,026

Organization	6 Months Ended
Organization	Jun. 30, 2016
Accounting Policies [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist. We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will generally not be subject to federal income tax in the United States (“U.S.”), provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both U.S. federal and state income taxes. For our properties located outside the U.S., we are subject to local taxes; however, we do not expect to incur additional taxes in the U.S. as such income will flow through our REIT. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are located in the U.S. and Europe.

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2016

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six month periods ended June 30, 2016, are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. The condensed consolidated balance sheet at December 31, 2015 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2015. During the six months ended June 30, 2016, there were no material changes to these policies.

Recent Accounting Developments:

Revenue from Contracts with Customers

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers. Under the new standard, revenue is recognized at the time a good or service is transferred to a customer for the amount of consideration received for that specific good or service. Entities may use a full retrospective approach or report the cumulative effect as of the date of adoption. On April 1, 2015, the FASB proposed deferring the effective date of this standard by one year to December 15, 2017, for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. We are continuing to evaluate this standard; however, we do not expect it to have a significant impact on our financial results, as a substantial portion of our revenue consists of rental income from leasing arrangements, which are specifically excluded from ASU No. 2014-09.

Leases

In February 2016, the FASB issued ASU 2016-02 - Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. The ASU is not effective for us until January 1, 2019 with early adoption permitted. We are continuing to evaluate this standard and the impact to us from both a lessor and a lessee perspective.

Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which is intended to improve financial reporting by requiring timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets not recorded at fair value based on historical experience, current conditions, and reasonable and supportable forecasts. The ASU will be required to be implemented through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the amendments are effective. The ASU is not effective for us until January 1, 2019. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.

Variable Interest Entities

At June 30, 2016, we had loans to and/or equity investments in certain variable interest entities (“VIEs”), which are also tenants of our facilities, including Ernest Health, Inc. (“Ernest”). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at June 30, 2016 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	295,822	Mortgage and other loans	$	226,101
Equity investments	$	37,309	Other assets	$	328

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investees) that most significantly impact the VIE’s economic performance. As of June 30, 2016, we were not required to provide any material financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 and 7 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Real Estate and Lending Activities

6 Months Ended

Jun. 30, 2016

Text Block [Abstract]

Real Estate and Lending Activities

3. Real Estate and Lending Activities

Acquisitions

We acquired the following assets (in thousands):


	Six Months Ended June 30,
	2016		2015
Assets Acquired
Land and land improvements	$	9,398	$	62,434
Building		37,593		390,320
Intangible lease assets — subject to amortization (weighted average useful life 25.8 years)		—		42,262
Mortgage loans		—		40,000
Net investments in direct financing leases		63,000		10,700
Other loans		—		16,917

Total assets acquired	$	109,991	$	562,633
Loans repaid (1)		—		(183,826	)

Total net assets acquired	$	109,991	$	378,807

(1)

Loans advanced to MEDIAN in 2014 and repaid in 2015 as a part of the MEDIAN transaction.

The purchase price allocations attributable to the 2016 and certain 2015 acquisitions are preliminary. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition dates that, if known, would have affected the measurement of the amounts recognized as of those dates.

2016 Activity

On May 2, 2016, we acquired an acute hospital in Newark, New Jersey for an aggregate purchase price of $63 million leased to Prime Healthcare Services, Inc. (“Prime”) pursuant to a fifth master lease, which has a 15-year term with three five-year extension options, plus consumer price-indexed increases, limited to a 2% floor. Furthermore, we committed to advance an additional $30 million to Prime over a three-year period to be used solely for capital additions to the real estate; any such additions will be added to the basis upon which the lessee will pay us rents.

On June 22, 2016, we closed on the final Median Kliniken S.à r.l., (“MEDIAN”) property for a purchase price of €41.6 million. See “2015 Activity” for a description of the initial MEDIAN Transaction.

From the respective acquisition dates, the properties acquired in 2016 contributed $1.1 million of revenue and income (excluding related acquisition expenses), for the three and six months ended June 30, 2016. In addition, we incurred $2.4 million of acquisition-related costs on the 2016 acquisitions for both the three and six months ended June 30, 2016.

2015 Activity

MEDIAN Transaction

On April 29, 2015, we entered into a series of definitive agreements with MEDIAN, a German provider of post-acute and acute rehabilitation services, to acquire the real estate assets of 32 hospitals owned by MEDIAN for an aggregate purchase price of approximately €688 million. Upon acquisition, each property became subject to a master lease between us and MEDIAN providing for the leaseback of the property to MEDIAN. The master lease had an initial term of 27 years and provided for an initial GAAP lease rate of 9.3%, with annual escalators at the greater of one percent or 70% of the German consumer price index.

MEDIAN is owned by an affiliate of Waterland Private Equity Fund V C.V. (“Waterland”), which acquired 94.9% of the outstanding equity interests in MEDIAN, and by a subsidiary of our operating partnership, which acquired the remaining 5.1% of the outstanding equity interests in MEDIAN, each in December 2014. In December 2014, we provided interim acquisition loans to affiliates of Waterland and MEDIAN in connection with Waterland’s acquisition of its stake in MEDIAN in an aggregate amount of approximately €425 million. In addition, we made further loans to MEDIAN during the first half of 2015 in an aggregate amount of approximately €240 million, which were used by MEDIAN to repay existing debt on properties we acquired.

Closing of the sale-leaseback transactions began in the second quarter of 2015. At each closing, the purchase price for each facility was reduced and offset against the interim loans made to affiliates of Waterland and MEDIAN as described above and against the amount of any debt assumed or repaid by us in connection with the closing. As of June 30, 2015, we had closed on 17 properties for an aggregate amount of €317 million.

Other Acquisitions

On June 16, 2015, we acquired the real estate of two facilities in Lubbock, Texas, a 60-bed inpatient rehabilitation hospital and a 37-bed long-term acute care hospital, for an aggregate purchase price of $31.5 million. We entered into a 20-year lease with Ernest for the rehabilitation hospital, which provides for three five-year extension options, and separately entered into a lease with Ernest for the long-term acute care hospital that has a final term ending December 31, 2034. In connection with the transaction, we funded an acquisition loan to Ernest of approximately $12.0 million. Ernest is operating the rehabilitation hospital in a joint venture with Covenant Health System, while the long-term acute care hospital continues to be operated by Fundamental Health under a new sublease with Ernest.

On February 27, 2015, we acquired an inpatient rehabilitation hospital in Weslaco, Texas for $10.7 million leased to Ernest pursuant to the 2012 master lease which had an original 20-year fixed term and three five-year extension options. This lease provides for consumer-priced-indexed annual rent increases, subject to a floor and a cap. In addition, we funded an acquisition loan in the amount of $5 million.

On February 13, 2015, we acquired two general acute care hospitals in the Kansas City area for $110 million. Affiliates of Prime is the tenant and operator pursuant to a new master lease that has similar terms and security enhancements as the other master lease agreements entered into in 2013. This master lease has a 10-year initial fixed term with two extension options of five years each. The lease provides for consumer-price-indexed annual rent increases, subject to a specified floor. In addition, we funded a mortgage loan in the amount of $40 million, which has a 10-year term.

From the respective acquisition dates, the properties and other assets acquired in 2015 contributed $4.2 million and $3.5 million of revenue and income (excluding related acquisition expenses), respectively, for the three months ended June 30, 2015. From the respective acquisition dates, the properties and other assets acquired in 2015 contributed $6.2 million and $4.9 million of revenue and income (excluding related acquisition expenses), respectively, for the six months ended June 30, 2015. In addition, we incurred $22.6 million and $26.7 million of acquisition-related costs on the 2015 acquisitions for the three and six months ended June 30, 2015, respectively.

Pro Forma Information

The following unaudited supplemental pro forma operating data is presented for the three and six months ended June 30, 2015, as if each acquisition (including completed development projects) was completed on January 1, 2015. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred. The unaudited supplemental pro forma operating data is not necessarily indicative of what the actual results of operations would have been assuming the transactions had been completed as set forth above, nor do they purport to represent our results of operations for future periods (in thousands, except per share/unit amounts).


	For the Three Months Ended June 30, 2015		For the Six Months Ended June 30, 2015
Total revenues	$	109	$	219
Net income	$	50	$	100
Net income per share/unit — diluted	$	0.21	$	0.42

Development Activities

During the first six months of 2016, we completed construction and began recording rental income on the following facilities:

•

Adeptus Health, Inc. (“Adeptus Health”) – We completed seven acute care facilities for this tenant during 2016. These facilities are leased pursuant to the master leases entered into in both 2014 and 2015 and are cross-defaulted with each other and with the original master lease executed in 2013.

•

Ernest Toledo – This inpatient rehabilitation facility located in Toledo, Ohio opened on April 1, 2016 and is being leased to Ernest pursuant to the original 2012 master lease.

See table below for a status update on our current domestic development projects (in thousands):


Property	Commitment		Costs Incurred as of 06/30/16		Estimated Completion Date
Adeptus Health	$	62,154	$	43,763		3Q 2016
Adeptus Health		53,836		15,343		4Q 2016
Adeptus Health		5,730		206		1Q 2017
Adeptus Health		61,997		16,311		2Q 2017
Adeptus Health		71,331		—		Various

	$	255,048	$	75,623

On September 9, 2015, we acquired the real estate of a general acute care hospital under development located in Spain, for an aggregate purchase and development price to us of approximately €21.4 million. The acquisition was effected through a joint venture between us and clients of AXA Real Estate, in which we will own a 50% interest. Upon completion, the facility will be leased to a Spanish operator of acute care hospitals, pursuant to a long-term lease. We expect construction to complete on this facility in the second quarter of 2017.

Disposals

Capella Transaction

On March 21, 2016, we entered into definitive agreements with RegionalCare Hospital Partners, Inc. (“RegionalCare”), an affiliate of certain funds managed by affiliates of Apollo Global Management, LLC (together with its consolidated subsidiaries, “Apollo”), under which our investment in the operations of Capella Healthcare, Inc. (“Capella”) would be merged with RegionalCare, forming RCCH Healthcare Partners (“RCCH”).

On April 29, 2016, this transaction closed and funded, effective April 30, 2016. As part of the transaction, we received net proceeds of approximately $550 million including approximately $492 million for our equity investment and loans made as part of the Capella transaction that closed on August 31, 2015. In addition, we received $210 million in prepayment of two mortgage loans for hospitals in Russellville, Arkansas, and Lawton, Oklahoma, that we made to subsidiaries of Capella in connection with the Capella transaction on August 31, 2015. We made a new $93.3 million loan for a hospital property in Olympia, Washington. Additionally, we and an Apollo affiliate invested $50 million each in unsecured senior notes issued by RegionalCare, which we sold to a large institution on June 20, 2016 at par. The proceeds from this transaction represented the recoverability of our investment in full, except for transaction costs incurred of $6.3 million.

We maintained our ownership of five Capella hospitals in Hot Springs, Arkansas; Camden, South Carolina; Hartsville, South Carolina; Muskogee, Oklahoma; and McMinnville, Oregon. Pursuant to the transaction described above, the underlying leases, one of which is a master lease covering all but one property, was amended to shorten the initial fixed lease term, increase the security deposit, and eliminate the lessees’ purchase option provisions. Due to this lease amendment, we reclassified the lease of the properties under the master lease from a direct finance lease (“DFL”) to an operating lease. This reclassification resulted in a write-off of $2.6 million in unbilled DFL rent in the 2016 second quarter.

On July 22, 2016, we acquired the Olympia, Washington property in exchange for the $93.3 million loan and an additional $7 million, which was contemplated in the original Capella transaction. The terms of the Olympia lease will be similar to the other leases with this tenant.

Post Acute Transaction

On May 23, 2016, we sold five properties (three of which were in Texas and two in Louisiana) that were leased and operated by Post Acute Medical (“Post Acute”). As part of this transaction, our outstanding loans of $4 million were paid in full, and we recovered our investment in the operations. Total proceeds from this transaction were $71 million resulting in a net gain of approximately $15 million.

Corinth Transaction

On June 17, 2016, we sold the Atrium Medical Center real estate located in Corinth, Texas, which was leased and operated by Corinth Investor Holdings. Total proceeds from the transaction were $28 million resulting in a gain on real estate of approximately $8 million. This gain on real estate was offset by approximately $9 million of non-cash charges that included the write-off of our investment in the operations of the facility, straight-line rent receivables, and a lease intangible.

HealthSouth Transaction

On May 20, 2016, we reached a firm commitment to sell three inpatient rehabilitation hospitals located in Texas and operated by HealthSouth Corporation (“HealthSouth”) for $111.5 million. At June 30, 2016, these facilities and related net assets were designated as held for sale and included the following (in thousands):


Real estate held for sale	$	63,074
Straight-line rent receivables		2,441
Other, net		(625	)

	$	64,890

On July 20, 2016, we completed this sale resulting in a net gain of approximately $45 million.

Summary of Operations for Disposed Assets

The properties which sold during the quarter and the assets held for sale at June 30, 2016, do not meet the definition of discontinued operations. However, the following represents the operating results (excluding gain on sale, transaction costs, and impairment or other non-cash charges) from these properties (excluding loans repaid in the Capella Transaction) for the periods presented (in thousands):


	For the Three Months						For the Six Months
	Ended June 30,						Ended June 30,
	2016			2015			2016			2015
Revenues	$	3,092		$	4,525		$	7,607		$	9,075
Real estate depreciation and amortization		(805	)		(949	)		(1,754	)		(1,897	)
Property-related expenses		(72	)		(12	)		(113	)		(72	)
Other income (expense)		(9	)		228			(68	)		557

Income from real estate dispositions, net	$	2,206		$	3,792		$	5,672		$	7,663

Leasing Operations

All of our leases are currently accounted for as operating leases except for the master lease of 15 Ernest facilities and six Prime facilities which are accounted for as DFLs. The components of our net investment in DFLs (which includes the Capella properties for 2015 only) consisted of the following (in thousands):


	As of June 30, 2016			As of December 31, 2015
Minimum lease payments receivable	$	1,875,751		$	2,587,912
Estimated residual values		292,646			393,097
Less: Unearned income		(1,639,650	)		(2,354,013	)

Net investment in direct financing leases	$	528,747		$	626,996

Twelve Oaks Facility

In the third quarter of 2015, we sent notice of termination of the lease to the tenant at our Twelve Oaks facility. This former tenant continues to occupy the facility. We called their letter of credit for approximately $0.5 million in the 2016 first quarter. At June 30, 2016, all past due receivables are fully reserved. Although no assurances can be made that we will not have any impairment charges in the future, we believe our real estate investment in Twelve Oaks at June 30, 2016 is fully recoverable.

Subsequent to June 30, 2016, we received approximately $2.5 million representing substantially all of amounts owed to us and agreed to general terms of a new lease, which we expect to execute during the 2016 third quarter.

Loans

The following is a summary of our loans (in thousands):


	As of June 30, 2016		As of December 31, 2015
Mortgage loans	$	549,337	$	757,581
Acquisition loans		216,100		610,469
Working capital and other loans		43,229		54,353

	$	808,666	$	1,422,403

The decrease in our mortgage and acquisition loans are related to the Capella Transaction as discussed previously.

Our non-mortgage loans typically consist of loans to our tenants for acquisitions and working capital purposes. At June 30, 2016, acquisition loans includes our original $93.2 million loan to Ernest and the $93.3 million loan to RCCH, which was repaid in July as discussed above.

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At June 30, 2016, $3.3 million remains outstanding on the convertible note, and we retain the option, subject to regulatory approvals, to convert this remainder into 15.1% of equity interest in the operator.

Concentrations of Credit Risk

Our revenue concentration for the six months ended June 30, 2016 as compared to the prior year is as follows (dollars in thousands):

Revenue by Operator


	For the Six Months Ended June 30, 2016					For the Six Months Ended June 30, 2015
Operators	Total Revenue		Percentage of Total Revenue			Total Revenue		Percentage of Total Revenue
Prime	$	58,859		22.5	%	$	49,869		25.5	%
MEDIAN		47,745		18.3	%		32,212		16.5	%
Ernest		33,322		12.8	%		29,695		15.2	%
RCCH		32,909		12.6	%		—		—
Adeptus Health		16,205		6.2	%		7,425		3.8	%

Revenue by U.S. State and Country


	For the Six Months Ended June 30, 2016					For the Six Months Ended June 30, 2015
U.S. States and Other Countries	Total Revenue		Percentage of Total Revenue			Total Revenue		Percentage of Total Revenue
Texas	$	48,256		18.5	%	$	42,689		21.8	%
California		33,187		12.7	%		33,065		16.9	%
All other states		129,896		49.7	%		85,620		43.7	%

Total U.S.	$	211,339		80.9	%	$	161,374		82.4	%
Germany	$	47,745		18.3	%	$	32,212		16.5	%
United Kingdom, Italy, and Spain		2,215		0.8	%		2,176		1.1	%

Total International	$	49,960		19.1	%	$	34,388		17.6	%

Grand Total	$	261,299		100.0	%	$	195,762		100.0	%

From an asset basis, our concentration as of June 30, 2016 as compared to December 31, 2015 is as follows (dollars in thousands):

Gross Assets by Operator


	As of June 30, 2016					As of December 31, 2015
Operators	Total Gross Assets		Percentage of Total Gross Assets			Total Gross Assets		Percentage of Total Gross Assets
	(A)		(B)			(A)		(B)
Prime	$	1,126,654		20.8	%	$	1,032,353		17.1	%
MEDIAN		1,054,368		19.4	%		1,031,039		17.1	%
Ernest		584,411		10.8	%		579,182		9.6	%
Adeptus Health		500,000		9.2	%		500,000		8.3	%
RCCH		458,659		8.5	%		1,059,989		17.6	%

Gross Assets by U.S. State and Country


	As of June 30, 2016					As of December 31, 2015
U.S. States and Other Countries	Total Gross Assets		Percentage of Total Gross Assets			Total Gross Assets		Percentage of Total Gross Assets
	(A)		(B)			(A)		(B)
Texas	$	920,959		17.0	%	$	1,060,990		17.6	%
California		547,079		10.1	%		547,085		9.1	%
All other states		2,530,018		46.6	%		3,047,204		50.5	%
Other domestic assets		189,358		3.5	%		177,317		2.9	%

Total U.S.	$	4,187,414		77.2	%	$	4,832,596		80.1	%
Germany	$	1,054,368		19.4	%	$	1,031,039		17.1	%
United Kingdom, Italy, and Spain		156,630		3.0	%		161,317		2.7	%
Other international assets		23,983		0.4	%		10,970		0.1	%

Total International	$	1,234,981		22.8	%	$	1,203,326		19.9	%

Grand Total	$	5,422,395		100.0	%	$	6,035,922		100.0	%

(A)	Gross Assets represents total assets plus accumulated depreciation/amortization assuming all real estate commitments as of the period end are fully funded.

(B)	Includes both leased and loaned assets.

On an individual property basis, we had no investment of any single property greater than 2.3% of our total assets as of June 30, 2016.

Debt

6 Months Ended

Jun. 30, 2016

Debt Disclosure [Abstract]

Debt

4. Debt

The following is a summary of our debt (dollar amounts in thousands):


	As of June 30, 2016						As of December 31, 2015
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facility	$	25,000			Variable		$	1,100,000			Variable
2006 Senior Unsecured Notes		125,000			Various			125,000			Various
2011 Senior Unsecured Notes		450,000			6.875	%		450,000			6.875	%
2012 Senior Unsecured Notes:
Principal amount		350,000			6.375	%		350,000			6.375	%
Unamortized premium		1,991						2,168

		351,991						352,168
2013 Senior Unsecured Notes (A)		222,120			5.750	%		217,240			5.750	%
2014 Senior Unsecured Notes		300,000			5.500	%		300,000			5.500	%
2015 Senior Unsecured Notes (A)		555,300			4.000	%		543,100			4.000	%
2016 Senior Unsecured Notes		500,000			6.375	%		—			—
Term loans		263,253			Various			263,400			Various

	$	2,792,664					$	3,350,908
Debt issue costs, net		(34,029	)					(28,367	)

	$	2,758,635					$	3,322,541

(A)	These notes are Euro-denominated and reflect the exchange rate at June 30, 2016 and December 31, 2015, respectively.

As of June 30, 2016, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (in thousands):


2016	$	125,152	(A)
2017		320
2018		37,781
2019		250,000
2020		222,120
Thereafter		2,155,300

Total	$	2,790,673

(A)	$65 million of our 2006 Senior Unsecured Notes were paid in full in July 2016, while the remaining $60 million will mature in October 2016.

On February 22, 2016, we completed a $500 million senior unsecured notes offering (“2016 Senior Unsecured Notes”), proceeds of which were used to repay borrowings under our revolving credit facility. Interest on the notes will be payable on March 1 and September 1 of each year, commencing on September 1, 2016. Interest on the notes will be paid in cash at a rate of 6.375% per year. The notes mature on March 1, 2024. We may redeem some or all of the notes at any time prior to March 1, 2019 at a “make whole” redemption price. On or after March 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase.

During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. The fair value of the interest rate swaps was $1.3 million and $2.9 million as of June 30, 2016 and December 31, 2015, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets.

We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness from inception of our interest rate swaps through June 30, 2016 and therefore, there was no income statement effect recorded during the three and six month periods ended June 30, 2016 or 2015. We do expect current losses included in accumulated other comprehensive loss to be reclassified into earnings through October 2016. At June 30, 2016 and December 31, 2015, we have posted $0.8 million and $1.7 million of collateral related to our interest rate swaps, respectively, which is reflected in other assets on our consolidated balance sheets.

Covenants

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and term loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations (“FFO”), as defined in the agreements, on a rolling four quarter basis. At June 30, 2016, the dividend restriction was 95% of normalized adjusted FFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the revolving credit facility and term loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, consolidated adjusted net worth, unsecured leverage ratio, and unsecured interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At June 30, 2016, we were in compliance with all such financial and operating covenants.

At June 30, 2016, the unsecured leverage ratio covenant was 77.5%. In September 2016, the unsecured leverage ratio will reset to 65%. We are currently in compliance with the reset leverage covenant.

Common Stock/Partners' Capital	6 Months Ended
Common Stock/Partners' Capital	Jun. 30, 2016
Equity [Abstract]
Common Stock/Partners' Capital	5. Common Stock/Partners’ Capital Medical Properties Trust, Inc. On March 1, 2016, we updated our at-the-market equity offering program, which gives us the ability to sell up to $227 million of stock with a commission rate of 1.25%. During the six months ended June 30, 2016, we sold approximately 3 million shares of our common stock under this program, resulting in net proceeds of approximately $45 million, after deducting approximately $0.6 million of commissions. On January 14, 2015, we completed an underwritten public offering of 34.5 million shares (including the exercise of the underwriters’ 30-day option to purchase an additional 4.5 million shares) of our common stock, resulting in net proceeds of approximately $480 million, after deducting estimated offering expenses. MPT Operating Partnership, L.P. At June 30, 2016, the Company has a 99.83% ownership interest in the Operating Partnership with the remainder owned by three other partners, two of whom are employees and one of whom is a director. During the six months ended June 30, 2016 and 2015, the Operating Partnership issued 3 million units and 34.5 million units, respectively, in direct response to the common stock offerings by Medical Properties Trust, Inc.

Stock Awards	6 Months Ended
Stock Awards	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Awards	6. Stock Awards We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2013, which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 8,196,770 shares of common stock for awards under the Equity Incentive Plan for which 5,615,497 shares remain available for future stock awards as of June 30, 2016. We awarded the following stock awards during 2016 and 2015: Time-based awards —We granted 45,528 shares to independent directors in 2016 and 217,177 shares to management, independent directors and certain employees in time-based restricted stock. These awards vest quarterly based on service, over three years, in equal amounts. Performance-based awards —Our management team and certain employees were awarded 176,046 shares of performance based awards in 2015. No such awards have been granted in 2016. These awards vest ratably over a three-year period based on the achievement of certain total shareholder return measures, with a carry-back and carry-forward provision through December 31, 2017. Dividends on these awards are paid only upon achievement of the performance measures. Multi-year Performance-based awards —We awarded 505,050 shares in 2015 of multi-year performance-based awards to management. No such awards have been granted in 2016. These shares are subject to three-year cumulative performance hurdles based on measures of total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes (excluding our 2006 Senior Unsecured Notes) using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, our revolving credit facility, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):


	June 30, 2016						December 31, 2015
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	47,699		$	47,653		$	46,939		$	46,858
Loans (1)		590,037			623,399			508,851			543,859
Debt, net		(2,758,635	)		(2,863,382	)		(3,322,541	)		(3,372,773	)

(1)	Excludes loans related to Ernest and Capella (2015 only) since they are recorded at fair value and discussed below.

Items Measured at Fair Value on a Recurring Basis

Our equity interest in Ernest and related loans, which were acquired in 2012, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans made in or prior to 2016, except for our investments in Capella that were disposed of in the 2016 second quarter.

At June 30, 2016, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	101,762	$	101,762		Mortgage loans
Acquisition and other loans		116,867		116,867		Other loans
Equity investments		3,300		3,300		Other assets

	$	221,929	$	221,929

Our mortgage loans with Ernest are recorded at fair value based on Level 2 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loans and equity investments in Ernest are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a marketability discount (“DLOM”) on our equity investment of 40% at June 30, 2016.

In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of Ernest’s historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry.

In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):


Basis Point Change in Marketability Discount	Estimated Increase (Decrease) In Fair Value
+100 basis points	$	(54	)
- 100 basis points		54

Because the fair value of Ernest investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during the first half of 2016 or 2015.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Earnings Per Share/Common Unit

6 Months Ended

Jun. 30, 2016

Earnings Per Share [Abstract]

Earnings Per Share/Common Unit

8. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (in thousands):


	For the Three Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	53,924		$	22,489
Non-controlling interests’ share in continuing operations		(200	)		(82	)
Participating securities’ share in earnings		(132	)		(250	)

Income from continuing operations, less participating securities’ share in earnings		53,592			22,157
Income from discontinued operations attributable to MPT common stockholders		—			—

Net income, less participating securities’ share in earnings	$	53,592		$	22,157

Denominator:
Basic weighted-average common shares		238,082			208,071
Dilutive potential common shares		926			569

Dilutive weighted-average common shares		239,008			208,640


	For the Six Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	112,150		$	58,465
Non-controlling interests’ share in continuing operations		(498	)		(161	)
Participating securities’ share in earnings		(276	)		(516	)

Income from continuing operations, less participating securities’ share in earnings		111,376			57,788
Loss from discontinued operations attributable to MPT common stockholders		(1	)		—

Net income, less participating securities’ share in earnings	$	111,375		$	57,788

Denominator:
Basic weighted-average common shares		237,796			205,515
Dilutive potential common shares		617			612

Dilutive weighted-average common shares		238,413			206,127

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (in thousands):


	For the Three Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	53,924		$	22,489
Non-controlling interests’ share in continuing operations		(200	)		(82	)
Participating securities’ share in earnings		(132	)		(250	)

Income from continuing operations, less participating securities’ share in earnings		53,592			22,157
Income from discontinued operations attributable to MPT Operating Partnership partners		—			—

Net income, less participating securities’ share in earnings	$	53,592		$	22,157

Denominator:
Basic weighted-average units		238,082			208,071
Dilutive potential units		926			569

Dilutive weighted-average units		239,008			208,640


	For the Six Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	112,150		$	58,465
Non-controlling interests’ share in continuing operations		(498	)		(161	)
Participating securities’ share in earnings		(276	)		(516	)

Income from continuing operations, less participating securities’ share in earnings		111,376			57,788
Loss from discontinued operations attributable to MPT Operating Partnership partners		(1	)		—

Net income, less participating securities’ share in earnings	$	111,375		$	57,788

Denominator:
Basic weighted-average units		237,796			205,515
Dilutive potential units		617			612

Dilutive weighted-average units		238,413			206,127

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	10. Subsequent Events Stock Issuance During the month of July, we sold 2.7 million shares of common stock under our at-the-market program generating net proceeds of $41.1 million. Bond Issuance On July 22, 2016, we completed a $500 million senior unsecured notes offering. Interest on the notes will be payable on February 1 and August 1 of each year, commencing on February 1, 2017. Interest on the notes will be paid in cash at a rate of 5.25% per year. The notes mature on August 1, 2026. We may redeem some or all of the notes at any time prior to August 1, 2021 at a “make whole” redemption price. On or after August 1, 2021, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to August 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 105.25% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase. We used the net proceeds from this offering to redeem our $450 million 2011 bonds, which will be completed on August 12, 2016. We expect to incur a one-time charge related to the redemption of approximately $23 million.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2016

Accounting Policies [Abstract]

Unaudited Interim Condensed Consolidated Financial Statements

Recent Accounting Developments

Recent Accounting Developments:

Revenue from Contracts with Customers

Leases

Measurement of Credit Losses on Financial Instruments

Variable Interest Entities

Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	295,822	Mortgage and other loans	$	226,101
Equity investments	$	37,309	Other assets	$	328

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

See Note 3 and 7 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2016

Accounting Policies [Abstract]

Carrying Value and Classification of Related Assets and Maximum Exposure to Loss

The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at June 30, 2016 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	295,822	Mortgage and other loans	$	226,101
Equity investments	$	37,309	Other assets	$	328

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Real Estate and Lending Activities (Tables)

6 Months Ended

Jun. 30, 2016

Text Block [Abstract]

Assets Acquired

We acquired the following assets (in thousands):


	Six Months Ended June 30,
	2016		2015
Assets Acquired
Land and land improvements	$	9,398	$	62,434
Building		37,593		390,320
Intangible lease assets — subject to amortization (weighted average useful life 25.8 years)		—		42,262
Mortgage loans		—		40,000
Net investments in direct financing leases		63,000		10,700
Other loans		—		16,917

Total assets acquired	$	109,991	$	562,633
Loans repaid (1)		—		(183,826	)

Total net assets acquired	$	109,991	$	378,807

(1)

Loans advanced to MEDIAN in 2014 and repaid in 2015 as a part of the MEDIAN transaction.

Schedule of Unaudited Supplemental Pro Forma Operating Data


	For the Three Months Ended June 30, 2015		For the Six Months Ended June 30, 2015
Total revenues	$	109	$	219
Net income	$	50	$	100
Net income per share/unit — diluted	$	0.21	$	0.42

Summary of Status Update on Current Development Projects

See table below for a status update on our current domestic development projects (in thousands):


Property	Commitment		Costs Incurred as of 06/30/16		Estimated Completion Date
Adeptus Health	$	62,154	$	43,763		3Q 2016
Adeptus Health		53,836		15,343		4Q 2016
Adeptus Health		5,730		206		1Q 2017
Adeptus Health		61,997		16,311		2Q 2017
Adeptus Health		71,331		—		Various

	$	255,048	$	75,623

Summary of Facilities and Related Net Assets Designated as Held for Sale

On May 20, 2016, we reached a firm commitment to sell three inpatient rehabilitation hospitals located in Texas and operated by HealthSouth for $111.5 million. At June 30, 2016, these facilities and related net assets were designated as held for sale and included the following (in thousands):


Real estate held for sale	$	63,074
Straight-line rent receivables		2,441
Other, net		(625	)

	$	64,890

Summary of Operations for Disposed Assets


	For the Three Months						For the Six Months
	Ended June 30,						Ended June 30,
	2016			2015			2016			2015
Revenues	$	3,092		$	4,525		$	7,607		$	9,075
Real estate depreciation and amortization		(805	)		(949	)		(1,754	)		(1,897	)
Property-related expenses		(72	)		(12	)		(113	)		(72	)
Other income (expense)		(9	)		228			(68	)		557

Income from real estate dispositions, net	$	2,206		$	3,792		$	5,672		$	7,663

Components of Net Investment in Direct Financing Leases

The components of our net investment in DFLs (which includes the Capella properties for 2015 only) consisted of the following (in thousands):


	As of June 30, 2016			As of December 31, 2015
Minimum lease payments receivable	$	1,875,751		$	2,587,912
Estimated residual values		292,646			393,097
Less: Unearned income		(1,639,650	)		(2,354,013	)

Net investment in direct financing leases	$	528,747		$	626,996

Summary of Loans

The following is a summary of our loans (in thousands):


	As of June 30, 2016		As of December 31, 2015
Mortgage loans	$	549,337	$	757,581
Acquisition loans		216,100		610,469
Working capital and other loans		43,229		54,353

	$	808,666	$	1,422,403

Schedule of Revenue by Operator

Revenue by Operator


	For the Six Months Ended June 30, 2016					For the Six Months Ended June 30, 2015
Operators	Total Revenue		Percentage of Total Revenue			Total Revenue		Percentage of Total Revenue
Prime	$	58,859		22.5	%	$	49,869		25.5	%
MEDIAN		47,745		18.3	%		32,212		16.5	%
Ernest		33,322		12.8	%		29,695		15.2	%
RCCH		32,909		12.6	%		—		—
Adeptus Health		16,205		6.2	%		7,425		3.8	%

Schedule of Revenue from External Customers by Geographic Areas

Revenue by U.S. State and Country


	For the Six Months Ended June 30, 2016					For the Six Months Ended June 30, 2015
U.S. States and Other Countries	Total Revenue		Percentage of Total Revenue			Total Revenue		Percentage of Total Revenue
Texas	$	48,256		18.5	%	$	42,689		21.8	%
California		33,187		12.7	%		33,065		16.9	%
All other states		129,896		49.7	%		85,620		43.7	%

Total U.S.	$	211,339		80.9	%	$	161,374		82.4	%
Germany	$	47,745		18.3	%	$	32,212		16.5	%
United Kingdom, Italy, and Spain		2,215		0.8	%		2,176		1.1	%

Total International	$	49,960		19.1	%	$	34,388		17.6	%

Grand Total	$	261,299		100.0	%	$	195,762		100.0	%

Schedule of Gross Assets by Operator

Gross Assets by Operator


	As of June 30, 2016					As of December 31, 2015
Operators	Total Gross Assets		Percentage of Total Gross Assets			Total Gross Assets		Percentage of Total Gross Assets
	(A)		(B)			(A)		(B)
Prime	$	1,126,654		20.8	%	$	1,032,353		17.1	%
MEDIAN		1,054,368		19.4	%		1,031,039		17.1	%
Ernest		584,411		10.8	%		579,182		9.6	%
Adeptus Health		500,000		9.2	%		500,000		8.3	%
RCCH		458,659		8.5	%		1,059,989		17.6	%

Schedule of Gross Assets by Geographic Areas

Gross Assets by U.S. State and Country


	As of June 30, 2016					As of December 31, 2015
U.S. States and Other Countries	Total Gross Assets		Percentage of Total Gross Assets			Total Gross Assets		Percentage of Total Gross Assets
	(A)		(B)			(A)		(B)
Texas	$	920,959		17.0	%	$	1,060,990		17.6	%
California		547,079		10.1	%		547,085		9.1	%
All other states		2,530,018		46.6	%		3,047,204		50.5	%
Other domestic assets		189,358		3.5	%		177,317		2.9	%

Total U.S.	$	4,187,414		77.2	%	$	4,832,596		80.1	%
Germany	$	1,054,368		19.4	%	$	1,031,039		17.1	%
United Kingdom, Italy, and Spain		156,630		3.0	%		161,317		2.7	%
Other international assets		23,983		0.4	%		10,970		0.1	%

Total International	$	1,234,981		22.8	%	$	1,203,326		19.9	%

Grand Total	$	5,422,395		100.0	%	$	6,035,922		100.0	%

(A)	Gross Assets represents total assets plus accumulated depreciation/amortization assuming all real estate commitments as of the period end are fully funded.

(B)	Includes both leased and loaned assets.

Debt (Tables)

6 Months Ended

Jun. 30, 2016

Debt Disclosure [Abstract]

Summary of Debt

The following is a summary of our debt (dollar amounts in thousands):


	As of June 30, 2016						As of December 31, 2015
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facility	$	25,000			Variable		$	1,100,000			Variable
2006 Senior Unsecured Notes		125,000			Various			125,000			Various
2011 Senior Unsecured Notes		450,000			6.875	%		450,000			6.875	%
2012 Senior Unsecured Notes:
Principal amount		350,000			6.375	%		350,000			6.375	%
Unamortized premium		1,991						2,168

		351,991						352,168
2013 Senior Unsecured Notes (A)		222,120			5.750	%		217,240			5.750	%
2014 Senior Unsecured Notes		300,000			5.500	%		300,000			5.500	%
2015 Senior Unsecured Notes (A)		555,300			4.000	%		543,100			4.000	%
2016 Senior Unsecured Notes		500,000			6.375	%		—			—
Term loans		263,253			Various			263,400			Various

	$	2,792,664					$	3,350,908
Debt issue costs, net		(34,029	)					(28,367	)

	$	2,758,635					$	3,322,541

(A)	These notes are Euro-denominated and reflect the exchange rate at June 30, 2016 and December 31, 2015, respectively.

Principal Payments Due on Debt

As of June 30, 2016, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (in thousands):


2016	$	125,152	(A)
2017		320
2018		37,781
2019		250,000
2020		222,120
Thereafter		2,155,300

Total	$	2,790,673

(A)	$65 million of our 2006 Senior Unsecured Notes were paid in full on in July 2016, while the remaining $60 million will mature in and October 2016.

Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2016

Fair Value Disclosures [Abstract]

Summary of Fair Value Information of Financial Instruments

The following table summarizes fair value estimates for our financial instruments (in thousands):


	June 30, 2016						December 31, 2015
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	47,699		$	47,653		$	46,939		$	46,858
Loans (1)		590,037			623,399			508,851			543,859
Debt, net		(2,758,635	)		(2,863,382	)		(3,322,541	)		(3,372,773	)

(1)	Excludes loans related to Ernest and Capella (2015 only) since they are recorded at fair value and discussed below.

Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis

At June 30, 2016, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	101,762	$	101,762		Mortgage loans
Acquisition and other loans		116,867		116,867		Other loans
Equity investments		3,300		3,300		Other assets

	$	221,929	$	221,929

Summary Showing Sensitivity Analysis by Using Basis Point Variations

To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):


Basis Point Change in Marketability Discount	Estimated Increase (Decrease) In Fair Value
+100 basis points	$	(54	)
- 100 basis points		54

Earnings Per Share/Common Unit (Tables)

6 Months Ended

Jun. 30, 2016

Earnings Per Share [Abstract]

Calculation of Earnings Per Share

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (in thousands):


	For the Three Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	53,924		$	22,489
Non-controlling interests’ share in continuing operations		(200	)		(82	)
Participating securities’ share in earnings		(132	)		(250	)

Income from continuing operations, less participating securities’ share in earnings		53,592			22,157
Income from discontinued operations attributable to MPT common stockholders		—			—

Net income, less participating securities’ share in earnings	$	53,592		$	22,157

Denominator:
Basic weighted-average common shares		238,082			208,071
Dilutive potential common shares		926			569

Dilutive weighted-average common shares		239,008			208,640


	For the Six Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	112,150		$	58,465
Non-controlling interests’ share in continuing operations		(498	)		(161	)
Participating securities’ share in earnings		(276	)		(516	)

Income from continuing operations, less participating securities’ share in earnings		111,376			57,788
Loss from discontinued operations attributable to MPT common stockholders		(1	)		—

Net income, less participating securities’ share in earnings	$	111,375		$	57,788

Denominator:
Basic weighted-average common shares		237,796			205,515
Dilutive potential common shares		617			612

Dilutive weighted-average common shares		238,413			206,127

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (in thousands):


	For the Three Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	53,924		$	22,489
Non-controlling interests’ share in continuing operations		(200	)		(82	)
Participating securities’ share in earnings		(132	)		(250	)

Income from continuing operations, less participating securities’ share in earnings		53,592			22,157
Income from discontinued operations attributable to MPT Operating Partnership partners		—			—

Net income, less participating securities’ share in earnings	$	53,592		$	22,157

Denominator:
Basic weighted-average units		238,082			208,071
Dilutive potential units		926			569

Dilutive weighted-average units		239,008			208,640


	For the Six Months Ended June 30,
	2016			2015
Numerator:
Income from continuing operations	$	112,150		$	58,465
Non-controlling interests’ share in continuing operations		(498	)		(161	)
Participating securities’ share in earnings		(276	)		(516	)

Income from continuing operations, less participating securities’ share in earnings		111,376			57,788
Loss from discontinued operations attributable to MPT Operating Partnership partners		(1	)		—

Net income, less participating securities’ share in earnings	$	111,375		$	57,788

Denominator:
Basic weighted-average units		237,796			205,515
Dilutive potential units		617			612

Dilutive weighted-average units		238,413			206,127

Summary of Significant Accounting Policies - Carrying Value and Classification of Related Assets and Maximum Exposure to Loss (Detail)	Jun. 30, 2016 USD ($)
Mortgage and other loans [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 226,101,000
Loans, net [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	295,822,000
Other Assets [Member]
Variable Interest Entity [Line Items]
Carrying Amount	328,000
Equity investments [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	$ 37,309,000

Real Estate and Lending Activities - Assets Acquired (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Jun. 30, 2015
Business Acquisition [Line Items]
Total assets acquired	$ 109,991	$ 562,633
Loans repaid		(183,826)
Total net assets acquired	109,991	378,807
Land and Land Improvements [Member]
Business Acquisition [Line Items]
Total assets acquired	9,398	62,434
Building [Member]
Business Acquisition [Line Items]
Total assets acquired	37,593	390,320
Intangible Lease Assets - Subject to Amortization [Member]
Business Acquisition [Line Items]
Total assets acquired		42,262
Net Investments in Direct Financing Leases [Member]
Business Acquisition [Line Items]
Total assets acquired	$ 63,000	10,700
Other Loans [Member]
Business Acquisition [Line Items]
Total assets acquired		16,917
Mortgage Loans [Member]
Business Acquisition [Line Items]
Total assets acquired		$ 40,000

Real Estate and Lending Activities - Assets Acquired (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2015
Intangible Lease Assets - Subject to Amortization [Member]
Business Acquisition [Line Items]
Weighted average useful life of acquired intangible lease assets (in years)	25 years 9 months 18 days

Real Estate and Lending Activities - 2016 Activity - Additional Information (Detail) $ in Thousands, € in Millions		3 Months Ended		6 Months Ended
	May 02, 2016 USD ($) RenewalOptions	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 22, 2016 EUR (€)
Business Acquisition [Line Items]
Acquisition related costs		$ 4,767	$ 25,809	$ 3,702	$ 32,048
Median [Member]
Business Acquisition [Line Items]
Value of properties closed \| €						€ 41.6
Acute Care Hospital [Member] \| New Jersey [Member]
Business Acquisition [Line Items]
Term of lease, years	15 years
Number of lease extension options \| RenewalOptions	3
Increase in consumer price-index, floor rate	2.00%
Commitment to advance an additional amount for capital additions	$ 30,000
Commitment period to advance an additional amount for capital additions	3 years
Acquisition costs	$ 63,000
Business Acquisitions [Member] \| 2016 [Member]
Business Acquisition [Line Items]
Revenue contributed by the acquired entity		1,100		1,100
Acquisition related costs		$ 2,400		$ 2,400

Real Estate and Lending Activities - 2015 Activity - Additional Information (Detail) $ in Thousands, € in Millions						3 Months Ended		6 Months Ended
	Jun. 30, 2015 EUR (€) Property	Jun. 16, 2015 USD ($) RenewalOptions Property Bed	Apr. 29, 2015 EUR (€) Hospital	Feb. 27, 2015 USD ($) RenewalOptions	Feb. 13, 2015 USD ($) Facility RenewalOptions	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 22, 2016 EUR (€)	Dec. 31, 2014 EUR (€)
Business Acquisition [Line Items]
Income contributed by the acquired entity							$ 50		$ 100
Acquisition related costs						$ 4,767	25,809	$ 3,702	32,048
Median [Member]
Business Acquisition [Line Items]
Value of properties closed \| €										€ 41.6
2015 [Member] \| Ernest [Member]
Business Acquisition [Line Items]
Acquisition costs		$ 31,500
Term of lease, years		20 years
Loans provided for acquisition		$ 12,000
Number of properties acquired \| Property		2
Number of lease extension options \| RenewalOptions		3
Term of lease extension, years		5 years
2015 [Member] \| Inpatient Rehabilitation Hospital [Member] \| Ernest [Member] \| Weslaco Texas [Member]
Business Acquisition [Line Items]
Acquisition costs				$ 10,700
Number of lease extension options \| RenewalOptions				3
Term of lease extension, years				5 years
Payments to fund long-term loans to related parties				$ 5,000
Lease original term				17 years
2015 [Member] \| Acute Care Hospital [Member] \| Kansas [Member]
Business Acquisition [Line Items]
Term of lease, years					10 years
Number of lease extension options \| RenewalOptions					2
Term of lease extension, years					5 years
Number of facilities acquired \| Facility					2
Purchase price of acquisition					$ 110,000
Mortgage financing					$ 40,000
Mortgage financing term					10 years
2015 [Member] \| Acute Care Hospital [Member] \| Ernest [Member]
Business Acquisition [Line Items]
Number of beds acquired \| Bed		37
2015 [Member] \| Rehabilitation Hospital with Covenant Health System [Member] \| Ernest [Member]
Business Acquisition [Line Items]
Number of beds acquired \| Bed		60
2015 [Member] \| Median [Member]
Business Acquisition [Line Items]
Number of hospitals acquired \| Hospital			32
Acquisition costs \| €			€ 688.0
Term of lease, years			27 years
Lease rent increase percentage			70.00%
Lease rate			9.30%
Ownership percentage											5.10%
Loans provided for acquisition \| €	€ 240.0										€ 425.0
Number of properties closed \| Property	17
Value of properties closed \| €	€ 317.0
2015 [Member] \| Waterland Private Equity Fund [Member] \| Median [Member]
Business Acquisition [Line Items]
Ownership percentage											94.90%
2015 [Member] \| Business Acquisitions [Member]
Business Acquisition [Line Items]
Revenue contributed by the acquired entity							4,200		6,200
Income contributed by the acquired entity							3,500		4,900
Acquisition related costs							$ 22,600		$ 26,700

Real Estate and Lending Activities - Schedule of Unaudited Supplemental Pro Forma Operating Data (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2015
Business Acquisition, Pro Forma Information [Abstract]
Total revenues	$ 109	$ 219
Net income	$ 50	$ 100
Net income per share/unit - diluted	$ 0.21	$ 0.42

Real Estate and Lending Activities - Development Activities - Additional Information (Detail) € in Millions	Sep. 09, 2015 EUR (€)	Jun. 30, 2016 Facility
2015 [Member] \| AXA Real Estate [Member]
Business Acquisition [Line Items]
Ownership interest in joint venture under the equity method	50.00%
Acute Care Facilities in Altoona [Member] \| Development Activities [Member]
Business Acquisition [Line Items]
Number of facilities constructed \| Facility		7
Acute Care Hospital [Member] \| 2015 [Member] \| Spain [Member] \| AXA Real Estate [Member]
Business Acquisition [Line Items]
Estimated total development cost \| €	€ 21.4

Real Estate and Lending Activities - Summary of Status Update on Current Development Projects (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2016 USD ($)
Business Acquisition [Line Items]
Commitment	$ 255,048
Costs Incurred as of 06/30/16	75,623
Adeptus Health One [Member]
Business Acquisition [Line Items]
Commitment	62,154
Costs Incurred as of 06/30/16	$ 43,763
Estimated Completion Date	3Q 2016
Adeptus Health Two [Member]
Business Acquisition [Line Items]
Commitment	$ 53,836
Costs Incurred as of 06/30/16	$ 15,343
Estimated Completion Date	4Q 2016
Adeptus Health Three [Member]
Business Acquisition [Line Items]
Commitment	$ 5,730
Costs Incurred as of 06/30/16	$ 206
Estimated Completion Date	1Q 2017
Adeptus Health Four [Member]
Business Acquisition [Line Items]
Commitment	$ 61,997
Costs Incurred as of 06/30/16	$ 16,311
Estimated Completion Date	2Q 2017
Adeptus Health Five [Member]
Business Acquisition [Line Items]
Commitment	$ 71,331
Estimated Completion Date	Various

Real Estate and Lending Activities - Disposals - Additional Information (Detail) $ in Millions						3 Months Ended	6 Months Ended
	Jul. 20, 2016 USD ($)	Jun. 17, 2016 USD ($)	May 23, 2016 USD ($) Property	May 20, 2016 USD ($) Hospital	Apr. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2016 Hospital	Jul. 22, 2016 USD ($)
Capella [Member]
Debt Instrument [Line Items]
Net proceeds from transaction					$ 550.0
Net proceeds from equity investment and loans					492.0
Proceeds from prepayment of mortgage loans					210.0
New loan for hospital property					93.3
Investment on unsecured senior notes					50.0
Transaction costs incurred					$ 6.3
Number of hospital owned \| Hospital							5
Write off of unbilled direct finance lease rent						$ 2.6
Capella [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Sale and leaseback arrangement								$ 93.3
Additional fund								$ 7.0
Post Acute [Member]
Debt Instrument [Line Items]
Number of properties sold \| Property			5
Outstanding loans paid in full			$ 4.0
Proceeds from sale of facilities		$ 28.0	71.0
Gain on real estate dispositions		8.0	$ 15.0
Post Acute [Member] \| Texas [Member]
Debt Instrument [Line Items]
Number of properties sold \| Property			3
Gain offset by non-cash charges		$ 9.0
Post Acute [Member] \| Louisiana [Member]
Debt Instrument [Line Items]
Number of properties sold \| Property			2
HealthSouth [Member]
Debt Instrument [Line Items]
Proceeds from sale of facilities				$ 111.5
HealthSouth [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Gain on real estate dispositions	$ 45.0
HealthSouth [Member] \| Texas [Member]
Debt Instrument [Line Items]
Number of hospitals sold \| Hospital				3

Real Estate and Lending Activities - Summary of Facilities and Related Net Assets Designated as Held for Sale (Detail) - Texas [Member] - HealthSouth [Member] $ in Thousands	Jun. 30, 2016 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate held for sale	$ 63,074
Straight-line rent receivables	2,441
Other, net	(625)
Assets held for sale, Net	$ 64,890

Real Estate and Lending Activities - Summary of Operations for Disposed Assets (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Revenues	$ 3,092	$ 4,525	$ 7,607	$ 9,075
Real estate depreciation and amortization	(805)	(949)	(1,754)	(1,897)
Property-related expenses	(72)	(12)	(113)	(72)
Other income (expense)	(9)	228	(68)	557
Income from real estate dispositions, net	$ 2,206	$ 3,792	$ 5,672	$ 7,663

Real Estate and Lending Activities - Leasing Operations - Additional Information (Detail) - Leasing Operations [Member]	6 Months Ended
	Jun. 30, 2016 Leases
Ernest [Member]
Business Acquisition [Line Items]
Number of direct financing leases	15
Prime Facilities [Member]
Business Acquisition [Line Items]
Number of direct financing leases	6

Real Estate and Lending Activities - Components of Net Investment in Direct Financing Leases (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Business Combinations [Abstract]
Minimum lease payments receivable	$ 1,875,751	$ 2,587,912
Estimated residual values	292,646	393,097
Less: Unearned income	(1,639,650)	(2,354,013)
Net investment in direct financing leases	$ 528,747	$ 626,996

Real Estate and Lending Activities - Twelve Oaks Facility - Additional Information (Detail) - Twelve Oaks Facility [Member] - USD ($) $ in Millions	Aug. 08, 2016	Mar. 31, 2016
Business Acquisition [Line Items]
Letter of credit outstanding		$ 0.5
Subsequent Event [Member]
Business Acquisition [Line Items]
Outstanding amount receivable from tenant past due including interest	$ 2.5

Real Estate and Lending Activities - Summary of Loans (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Loans [Line Items]
Loans, Balance	$ 808,666	$ 1,422,403
Mortgage Loans [Member]
Loans [Line Items]
Loans, Balance	549,337	757,581
Acquisition Loans [Member]
Loans [Line Items]
Loans, Balance	216,100	610,469
Working Capital and Other Loans [Member]
Loans [Line Items]
Loans, Balance	$ 43,229	$ 54,353

Real Estate and Loans Receivable - Loans - Additional Information (Detail) - USD ($) $ in Millions		6 Months Ended
	Mar. 01, 2012	Jun. 30, 2016
Business Acquisition [Line Items]
Amount of convertible note converted into equity interest	$ 1.7
Convertible note	$ 5.0
Percentage of equity shares from convertible debt	9.90%	15.10%
Remaining convertible debt after conversion of part of debt		$ 3.3
Ernest Transaction and Other Acquisitions [Member]
Business Acquisition [Line Items]
Existing mortgage loans		93.2
RCCH [Member]
Business Acquisition [Line Items]
Existing mortgage loans		$ 93.3

Real Estate and Lending Activities - Schedule of Revenue by Operator (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Investment And Revenue From External Customers [Line Items]
Total Revenue	$ 126,300	$ 99,801	$ 261,299	$ 195,762
Revenue [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 261,299	$ 195,762
Percentage of Total Revenue			100.00%	100.00%
Revenue [Member] \| Credit Concentration Risk [Member] \| Prime [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 58,859	$ 49,869
Percentage of Total Revenue			22.50%	25.50%
Revenue [Member] \| Credit Concentration Risk [Member] \| Median [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 47,745	$ 32,212
Percentage of Total Revenue			18.30%	16.50%
Revenue [Member] \| Credit Concentration Risk [Member] \| Ernest [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 33,322	$ 29,695
Percentage of Total Revenue			12.80%	15.20%
Revenue [Member] \| Credit Concentration Risk [Member] \| RCCH [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 32,909
Percentage of Total Revenue			12.60%
Revenue [Member] \| Credit Concentration Risk [Member] \| Adeptus Health [Member]
Investment And Revenue From External Customers [Line Items]
Total Revenue			$ 16,205	$ 7,425
Percentage of Total Revenue			6.20%	3.80%

Real Estate and Lending Activities - Schedule of Revenue from External Customers by Geographic Areas (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue	$ 126,300	$ 99,801	$ 261,299	$ 195,762
Revenue [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 261,299	$ 195,762
Percentage of Total Revenue			100.00%	100.00%
Revenue [Member] \| Texas [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 48,256	$ 42,689
Percentage of Total Revenue			18.50%	21.80%
Revenue [Member] \| California [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 33,187	$ 33,065
Percentage of Total Revenue			12.70%	16.90%
Revenue [Member] \| All Other States [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 129,896	$ 85,620
Percentage of Total Revenue			49.70%	43.70%
Revenue [Member] \| United States [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 211,339	$ 161,374
Percentage of Total Revenue			80.90%	82.40%
Revenue [Member] \| Germany [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 47,745	$ 32,212
Percentage of Total Revenue			18.30%	16.50%
Revenue [Member] \| United Kingdom, Italy, and Spain [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 2,215	$ 2,176
Percentage of Total Revenue			0.80%	1.10%
Revenue [Member] \| International [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Revenue			$ 49,960	$ 34,388
Percentage of Total Revenue			19.10%	17.60%

Real Estate and Lending Activities - Schedule of Gross Assets by Operator (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 5,117,933	$ 5,609,351
Assets, Total [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 5,422,395	$ 6,035,922
Percentage of Total Gross Assets	100.00%	100.00%
Assets, Total [Member] \| Credit Concentration Risk [Member] \| Prime [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 1,126,654	$ 1,032,353
Percentage of Total Gross Assets	20.80%	17.10%
Assets, Total [Member] \| Credit Concentration Risk [Member] \| Median [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 1,054,368	$ 1,031,039
Percentage of Total Gross Assets	19.40%	17.10%
Assets, Total [Member] \| Credit Concentration Risk [Member] \| Ernest [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 584,411	$ 579,182
Percentage of Total Gross Assets	10.80%	9.60%
Assets, Total [Member] \| Credit Concentration Risk [Member] \| Adeptus Health [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 500,000	$ 500,000
Percentage of Total Gross Assets	9.20%	8.30%
Assets, Total [Member] \| Credit Concentration Risk [Member] \| RCCH [Member]
Investment And Revenue From External Customers [Line Items]
Total Gross Assets	$ 458,659	$ 1,059,989
Percentage of Total Gross Assets	8.50%	17.60%

Real Estate and Lending Activities - Schedule of Gross Assets by Geographic Areas (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 5,117,933	$ 5,609,351
Assets, Total [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 5,422,395	$ 6,035,922
Percentage of Total Gross Assets	100.00%	100.00%
Assets, Total [Member] \| Texas [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 920,959	$ 1,060,990
Percentage of Total Gross Assets	17.00%	17.60%
Assets, Total [Member] \| California [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 547,079	$ 547,085
Percentage of Total Gross Assets	10.10%	9.10%
Assets, Total [Member] \| All Other States [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 2,530,018	$ 3,047,204
Percentage of Total Gross Assets	46.60%	50.50%
Assets, Total [Member] \| Other Domestic Assets [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 189,358	$ 177,317
Percentage of Total Gross Assets	3.50%	2.90%
Assets, Total [Member] \| United States [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 4,187,414	$ 4,832,596
Percentage of Total Gross Assets	77.20%	80.10%
Assets, Total [Member] \| Germany [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 1,054,368	$ 1,031,039
Percentage of Total Gross Assets	19.40%	17.10%
Assets, Total [Member] \| United Kingdom, Italy, and Spain [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 156,630	$ 161,317
Percentage of Total Gross Assets	3.00%	2.70%
Assets, Total [Member] \| Other International Assets [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 23,983	$ 10,970
Percentage of Total Gross Assets	0.40%	0.10%
Assets, Total [Member] \| International [Member] \| Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Gross Assets	$ 1,234,981	$ 1,203,326
Percentage of Total Gross Assets	22.80%	19.90%

Real Estate and Lending Activities - Concentrations of Credit Risk - Additional Information (Detail) - Assets, Total [Member] - Customer Concentration Risk [Member]	Jun. 30, 2016 Investment
Business Acquisition [Line Items]
Number of investment in property	0
Maximum percentage of entity's total assets invested on single property	2.30%

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Feb. 22, 2016
Debt Instrument [Line Items]
Principal amount	$ 2,790,673
Debt issue costs, net	(34,029)	$ (28,367)
Debt	$ 2,758,635	$ 3,322,541
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	Variable	Variable
Debt	$ 25,000	$ 1,100,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 125,000	$ 125,000
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.875%	6.875%
Debt	$ 450,000	$ 450,000
2012 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 350,000	$ 350,000
Senior unsecured notes, interest rate	6.375%	6.375%
Unamortized premium	$ 1,991	$ 2,168
Debt	$ 351,991	$ 352,168
2013 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.75%	5.75%
Debt	$ 222,120	$ 217,240
2014 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.50%	5.50%
Debt	$ 300,000	$ 300,000
2015 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	4.00%	4.00%
Debt	$ 555,300	$ 543,100
2016 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.375%
Debt	$ 500,000
2016 Senior Unsecured Notes [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate			6.375%
Term Loans [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 263,253	$ 263,400
Senior Unsecured Debt [Member]
Debt Instrument [Line Items]
Debt	$ 2,792,664	$ 3,350,908

Debt - Principal Payments Due for Debt (Detail) $ in Thousands	Jun. 30, 2016 USD ($)
Debt Disclosure [Abstract]
2016	$ 125,152
2017	320
2018	37,781
2019	250,000
2020	222,120
Thereafter	2,155,300
Total	$ 2,790,673

Debt - Principal Payments Due for Debt (Parenthetical) (Detail) - 2006 Senior Unsecured Notes [Member] - USD ($) $ in Millions	Oct. 31, 2016	Jul. 31, 2016
Subsequent Event [Member]
Debt Instrument [Line Items]
Unsecured debt, current		$ 65
Scenario, Forecast [Member]
Debt Instrument [Line Items]
Unsecured debt, current	$ 60

Debt - Additional Information (Detail) - USD ($)		1 Months Ended	6 Months Ended
Debt - Additional Information (Detail) - USD ($)	Feb. 22, 2016	Oct. 31, 2011	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2010
2016 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate			6.375%
2006 Senior Unsecured Notes [Member] \| Interest Rate Swap [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount					$ 65,000,000
2006 Senior Unsecured Notes [Member] \| Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps			$ 1,300,000	$ 2,900,000
2006 Senior Unsecured Notes [Member] \| Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument					5.507%
Maturity date of interest rate swap			2016-07
2006 Senior Unsecured Notes [Member] \| Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Maturity date of interest rate swap			2016-10
Interest rate swap, amount fixed		$ 60,000,000
Interest rate of derivative instrument		5.675%
Revolving Credit Facility [Member] \| 2016 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount	$ 500,000,000
Senior unsecured notes, maturity date	Mar. 01, 2024
Senior unsecured notes, interest rate	6.375%
Debt instrument, redemption price percentage	106.375%
Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest	101.00%
Senior unsecured notes, payable term	Interest on the notes will be payable on March 1 and September 1 of each year
Senior unsecured notes commencing date of payment	Sep. 01, 2016
Senior notes, earliest redemption date	Mar. 01, 2019
Senior unsecured notes, redemption description	We may redeem some or all of the notes at any time prior to March 1, 2019 at a “make whole” redemption price. On or after March 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase.
Revolving Credit Facility [Member] \| 2016 Senior Unsecured Notes [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Senior unsecured notes, redemption percentage on principal amount	35.00%

Debt - Interest Rate Swap - Additional Information (Detail) - Interest Rate Swap [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Hedge ineffectiveness and income statement effect in period	$ 0	$ 0	$ 0	$ 0
Other assets, collateral	$ 800,000		$ 800,000		$ 1,700,000

Debt - Covenants - Additional Information (Detail)	6 Months Ended
Debt - Covenants - Additional Information (Detail)	Jun. 30, 2016	Sep. 30, 2016
Debt Instrument [Line Items]
Percentage of dividends which could be paid from adjusted operating funds	95.00%
Percentage of dividends which could be paid from operation funds	95.00%
Maximum percentage of total unencumbered assets	150.00%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Unsecured leverage ratio	77.50%
Scenario, Forecast [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Unsecured leverage ratio		65.00%

Common Stock/Partners' Capital - Additional Information (Detail) shares in Thousands, $ in Thousands			6 Months Ended
	Mar. 01, 2016 USD ($)	Jan. 14, 2015 USD ($) shares	Jun. 30, 2016 USD ($) Partner Director Employee shares	Jun. 30, 2015 USD ($) shares	Dec. 31, 2015 shares
Class of Stock [Line Items]
Common stock, shares issued \| shares			240,341		236,744
Proceeds from sale of common shares / units, net of offering costs			$ 44,306	$ 479,902
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Proceeds from sale of common shares / units, net of offering costs			$ 44,306	$ 479,902
Ownership interest in equity			99.83%
Number of other partners \| Partner			3
Number of units sold \| shares			3,000	34,500
Employee [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage \| Employee			2
Director [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage \| Director			1
Market Equity Offering Program [Member]
Class of Stock [Line Items]
Sales commission percentage	1.25%
Common stock, shares issued \| shares			3,000
Proceeds from sale of common shares / units, net of offering costs			$ 45,000
Sales commissions, amount			$ 600
Market Equity Offering Program [Member] \| Maximum [Member]
Class of Stock [Line Items]
Value of stock	$ 227,000
Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued \| shares		34,500
Proceeds from sale of common shares / units, net of offering costs		$ 480,000
Additional shares purchased by underwriters \| shares		4,500

Stock Awards - Additional Information (Detail) - shares	6 Months Ended
Stock Awards - Additional Information (Detail) - shares	Jun. 30, 2016	Jun. 30, 2015
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	45,528	217,177
Stock awards vesting period in years	3 years
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	0	176,046
Stock awards vesting period in years	3 years
Multi-year performance-based awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	0	505,050
Stock awards vesting period in years	3 years
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	8,196,770
Common stock remaining for future stock awards transferred to the equity incentive plan	5,615,497

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Interest and rent receivables, Book value	$ 47,699	$ 46,939
Loans, Book value	590,037	508,851
Debt, net Book value	(2,758,635)	(3,322,541)
Interest and rent receivables, Fair value	47,653	46,858
Loans, Fair value	623,399	543,859
Debt, net Fair value	$ (2,863,382)	$ (3,372,773)

Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail) $ in Thousands	Jun. 30, 2016 USD ($)
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	$ 221,929
Cost	221,929
Fair Value Measurements, Recurring [Member] \| Equity investments [Member] \| Other Assets [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	3,300
Cost	3,300
Fair Value Measurements, Recurring [Member] \| Acquisition and Other Loans [Member] \| Other Loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	116,867
Cost	116,867
Fair Value Measurements, Recurring [Member] \| Mortgage Loans [Member] \| Mortgage Loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	101,762
Cost	$ 101,762

Fair Value of Financial Instruments - Additional information (Detail)	6 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Adjustment for marketability discount	40.00%

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2016 USD ($)
+100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ (54)
- 100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ 54

Earnings Per Share/Common Unit - Calculation of Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 53,924	$ 22,489	$ 112,150	$ 58,465
Non-controlling interests' share in continuing operations	(200)	(82)	(498)	(161)
Participating securities' share in earnings	(132)	(250)	(276)	(516)
Income from continuing operations, less participating securities' share in earnings	53,592	22,157	111,376	57,788
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners			(1)
Net income, less participating securities' share in earnings	$ 53,592	$ 22,157	$ 111,375	$ 57,788
Basic weighted-average common shares	238,082	208,071	237,796	205,515
Dilutive potential common shares	926	569	617	612
Dilutive weighted-average common shares	239,008	208,640	238,413	206,127
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 53,924	$ 22,489	$ 112,150	$ 58,465
Non-controlling interests' share in continuing operations	(200)	(82)	(498)	(161)
Participating securities' share in earnings	(132)	(250)	(276)	(516)
Income from continuing operations, less participating securities' share in earnings	53,592	22,157	111,376	57,788
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners			(1)
Net income, less participating securities' share in earnings	$ 53,592	$ 22,157	$ 111,375	$ 57,788
Basic weighted-average common shares	238,082	208,071	237,796	205,515
Dilutive potential common shares	926	569	617	612
Dilutive weighted-average common shares	239,008	208,640	238,413	206,127

Subsequent Events - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands		1 Months Ended	6 Months Ended
	Jul. 22, 2016	Jul. 31, 2016	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Subsequent Event [Line Items]
Common stock, shares issued			240,341		236,744
Proceeds from sale of common shares / units, net of offering costs			$ 44,306	$ 479,902
2016 Senior Unsecured Notes [Member]
Subsequent Event [Line Items]
Senior unsecured notes, interest rate			6.375%
2016 Senior Unsecured Notes [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Senior unsecured notes face amount	$ 500,000
Senior unsecured notes, maturity date	Aug. 01, 2026
Senior unsecured notes, interest rate	5.25%
Debt instrument, redemption price percentage	105.25%
Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest	101.00%
2016 Senior Unsecured Notes [Member] \| Subsequent Event [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Senior unsecured notes, redemption percentage on principal amount	35.00%
2011 Bonds [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Senior unsecured notes face amount	$ 450,000
2026 Senior Unsecured Notes [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Redemption period, end date	Aug. 12, 2016
Debt redemption value	$ 23,000
Senior unsecured notes, payable term	Interest on the notes will be payable on February 1 and August 1 of each year
Senior unsecured notes commencing date of payment	Feb. 01, 2017
Senior notes, earliest redemption date	Aug. 01, 2021
Senior unsecured notes, redemption description	We may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to August 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 105.25% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase.
Market Equity Offering Program [Member]
Subsequent Event [Line Items]
Common stock, shares issued			3,000
Proceeds from sale of common shares / units, net of offering costs			$ 45,000
Market Equity Offering Program [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares issued		2,700
Proceeds from sale of common shares / units, net of offering costs		$ 41,100